BFM
KZR

Boothbay Fund Management’s Kezar Life Sciences KZR Stock Holding History

Boothbay Fund Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,640
Closed -$1.13M – 2430
2022
Q2 		$1.13M Buy
13,640
+10,520
+337% +$928K 0.03% 761
2022
Q1 		$519K Buy
3,120
+1,210
+63% +$174K 0.01% 1270
2021
Q4 		$319K Buy
+1,910
New +$216K 0.01% 1228

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Boothbay Fund Management's KZR Position: Q1 2026 in Review

Boothbay Fund Management held its Kezar Life Sciences (KZR) position steady in Q1 2026 at 16,210 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Boothbay Fund Management first reported a position in KZR in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.89M in Q4 2021. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Boothbay Fund Management held 16,210 shares of Kezar Life Sciences worth $120K as of Q1 2026.
  • Boothbay Fund Management left its Kezar Life Sciences share count unchanged in Q1 2026.
  • Kezar Life Sciences made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1857 holding.
  • Boothbay Fund Management first reported a position in Kezar Life Sciences in Q4 2021 and has held it in 18 quarters since.
  • Boothbay Fund Management's Kezar Life Sciences position peaked at $1.89M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.